Common use of Adverse Reaction Reporting Clause in Contracts

Adverse Reaction Reporting. (a) Each Party shall record, evaluate, summarize and review all adverse drug experiences associated with the Compound and the Product. In order that each Party may be fully informed of the adverse drug experiences associated therewith that are known to the other Party, each Party shall report: (i) In the case of Inspire, to: Inspire Pharmaceuticals, Inc. ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇ Attention: ▇▇▇▇▇ ▇▇▇▇▇▇, Manager, Regulatory Affairs & Project Management Facsimile No.: (▇▇▇) ▇▇▇-▇▇▇▇ Telephone No.: (919) 941-9777 ext. 288 (ii) In the case of Santen, to: Santen Pharmaceutical Co., Ltd. ▇-▇-▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇-▇▇ ▇▇▇▇▇ ▇▇▇-▇▇▇▇ ▇▇▇▇▇ Attention: ▇▇▇▇ ▇▇▇▇▇▇▇▇, Ph.D., Deputy General Manager Facsimile No.: (▇▇) ▇▇▇▇-▇▇▇▇ Telephone No.: (▇▇) ▇▇▇▇-▇▇▇▇

Appears in 2 contracts

Sources: Development, License and Supply Agreement (Inspire Pharmaceuticals Inc), Development, License and Supply Agreement (Inspire Pharmaceuticals Inc)